Publication | Open Access

Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study

NanoparticlesNanomedicineEngineeringCholesterol-rich NanoparticlesMedicinePolymer-drug ConjugateTumor UptakeBreast CancerNano-drug DeliveryTumor TargetingPharmacologyRadiation Oncology